DaVita HealthCare (DVA) Laps the Stock Market: Here's Why

DaVita HealthCare (DVA) closed at $178.69, up 1.33%, outperforming the S&P 500's 0.73% gain. The kidney dialysis provider is projected to report earnings of $3.78 per share with 50.6% year-over-year growth. The stock trades at a Forward P/E of 12.1, below the industry average of 19.68, and holds a Zacks Rank of #3 (Hold) with a PEG ratio of 0.46, indicating potential value.